Synlett 2014; 25(4): 569-573
DOI: 10.1055/s-0033-1340553
letter
© Georg Thieme Verlag Stuttgart · New York

Synthesis of cis-5-Trifluoromethylproline from l-Glutamic Acid

Stéphanie Ortial
a   Institut des Biomolécules Max Mousseron (IBMM), UMR CNRS 5247, Université de Montpellier I & II, Place Eugène Bataillon, 34095 Montpellier Cedex 5, France
b   UNIVERSITE DE NIMES, Laboratoire de Chimie BioOrganique (LCBO), Place G. Péri, 30021 Nîmes Cedex 1, France   Fax: +33(4)66364587   Email: patrick.meffre@unimes.fr
,
Rajesh Dave
,
Zohra Benfodda
a   Institut des Biomolécules Max Mousseron (IBMM), UMR CNRS 5247, Université de Montpellier I & II, Place Eugène Bataillon, 34095 Montpellier Cedex 5, France
b   UNIVERSITE DE NIMES, Laboratoire de Chimie BioOrganique (LCBO), Place G. Péri, 30021 Nîmes Cedex 1, France   Fax: +33(4)66364587   Email: patrick.meffre@unimes.fr
,
David Bénimélis
a   Institut des Biomolécules Max Mousseron (IBMM), UMR CNRS 5247, Université de Montpellier I & II, Place Eugène Bataillon, 34095 Montpellier Cedex 5, France
b   UNIVERSITE DE NIMES, Laboratoire de Chimie BioOrganique (LCBO), Place G. Péri, 30021 Nîmes Cedex 1, France   Fax: +33(4)66364587   Email: patrick.meffre@unimes.fr
,
Patrick Meffre*
a   Institut des Biomolécules Max Mousseron (IBMM), UMR CNRS 5247, Université de Montpellier I & II, Place Eugène Bataillon, 34095 Montpellier Cedex 5, France
b   UNIVERSITE DE NIMES, Laboratoire de Chimie BioOrganique (LCBO), Place G. Péri, 30021 Nîmes Cedex 1, France   Fax: +33(4)66364587   Email: patrick.meffre@unimes.fr
› Author Affiliations
Further Information

Publication History

Received: 03 November 2013

Accepted after revision: 09 December 2013

Publication Date:
14 January 2014 (online)


Abstract

The diastereoselective synthesis of cis-5-trifluoromethylproline (5-Tfm-Pro) from l-glutamic acid is described. 5-Tfm-Pro could be obtained through a seven-step linear sequence. Trifluoromethylation of the glutamic-derived ester or aldehyde and subsequent reduction of the cyclic imine are the key steps in the synthesis.

Supporting Information

 
  • References and Notes

  • 1 Present address: Calyx Chemicals & Pharmaceuticals Ltd, A-37/38, MIDC, Dombivli East, Dist. Thane 421 203, Maharashtra, India.
  • 6 Chaume G, Van Severen M.-C, Marinkovic S, Brigaud T. Org. Lett. 2006; 8: 6123
  • 7 Caupène C, Chaume G, Ricard L, Brigaud T. Org. Lett. 2009; 11: 209
  • 8 Chaume G, Lensen N, Caupène C, Brigaud T. Eur. J. Org. Chem. 2009; 5717
  • 9 Jlalia I, Lensen N, Chaume G, Dzhambazova E, Astasidi L, Hadjiolova R, Bocheva A, Brigaud T. Eur. J. Med. Chem. 2013; 62: 122
  • 10 Gulevich AV, Shevchenko NE, Balenkova ES, Röschenthaler G.-V, Nenajdenko VG. Synlett 2009; 403
  • 11 Li Q, Ding C.-H, Li X.-H, Weissensteiner W, Hou X.-L. Synthesis 2012; 44: 265
  • 12 Li G.-H, Tong M.-C, Li J, Tao H.-Y, Wang C.-J. Chem. Commun. 2011; 47: 11110
  • 13 Li Q.-H, Xue Z.-Y, Tao H.-Y, Wang C.-J. Tetrahedron Lett. 2012; 53: 3650
  • 14 Qiu X.-L, Qing F.-L. J. Chem. Soc., Perkin Trans. 1 2002; 2052
  • 15 Qiu X.-L, Qing F.-L. J. Org. Chem. 2002; 67: 7162
  • 16 Del Valle JR, Goodman M. Angew. Chem. Int. Ed. 2002; 41: 1600
  • 17 Chaume G, Barbeau O, Lesot P, Brigaud T. J. Org. Chem. 2010; 75: 4135
  • 19 Khangarot RK, Kaliappan KP. Eur. J. Org. Chem. 2013; 13: 2692
  • 20 Kondratov IS, Dolovanyuk VG, Tolmachova NA, Gerus II, Bergander K, Fröhlich R, Haufe G. Org. Biomol. Chem. 2012; 10: 8778
  • 21 Padrón JM, Kokotos G, Martín T, Markidis T, Gibbons WA, Martín VS. Tetrahedron: Asymmetry 1998; 9: 3381
  • 22 Wiedemann J, Heiner T, Mloston G, Prakash GK. S, Olah GA. Angew. Chem. Int. Ed. 1998; 37: 820
  • 23 The level of drying of all reagents and solvents required for this reaction might be the cause of the capricious nature of this transformation as discussed by the authors (Note: commercially available 1 M solution of TBAF in THF usually contains 5% of H2O).
  • 24 Adamczyk M, Johnson DD, Reddy RE. Tetrahedron: Asymmetry 1999; 10: 775
  • 25 Ilies M, Dowling DP, Lombardi PM, Christianson DW. Bioorg. Med. Chem. Lett. 2011; 21: 5854
  • 26 Bodanszky M, Bodanszky A In The Practice of Peptide Synthesis . Springer Verlag; Berlin: 1984: 177
  • 27 Experimental Procedure for 6: Using 4 M HCl–1 M NaOH: Compound 5 (1.2 mmol, 1 equiv) was dissolved in THF (10 mL) and a THF–12 M HCl mixture (11 mL/9 mL) was added dropwise and the solution was stirred at r.t. for 30 min. After concentration in vacuo, MeOH (2.4 mL) and 1 M NaOH (3.36 mL) were added to the crude product. The solution was stirred at r.t. for 2 h and concentrated in vacuo. Purification over Dowex 50WX8, eluting with H2O then 5% aq NH3 followed by purification over RP 18 silica gel, eluting with H2O afforded the imine 6 as an off-white solid after complete removal of the H2O (0.15 g, 0.83 mmol, 69%). Using 6 M HCl: Compound 5 (0.84 mmol, 1 equiv) was dissolved in 6 M HCl (3.5 mL). The solution was heated at 60 °C until reaction was complete (24 h) and the brown mixture then washed with Et2O (2 ×) and concentrated in vacuo. Purification following the procedure previously described afforded 6 in 59% yield (0.09 g, 0.50 mmol). 1H NMR (300 MHz, DMSO-d 6): δ = 4.62 (m, 1 H), 2.76 (m, 2 H), 2.13 (m, 2 H). 13C NMR (75.45 MHz, DMSO-d 6): δ = 173.3 (C), 164.3 (q, J CCF = 34.8 Hz, C), 120.5 (q, J CF = 273 Hz, C), 77.9 (CH), 33.5, 27.0 (CH2). 19F NMR (282.4 MHz, DMSO-d 6): δ = −68.8 (d, J HF = 2.8 Hz). [α]D 20 6.1 (c = 1.0, DMSO). HRMS (ESI−): m/z [M − H] calcd for C6H5NO2F3: 180.0272; found: 180.0273.
  • 29 Experimental Procedure for 7: The cyclic imine 6 (0.27 mmol, 1 equiv) was dissolved in anhyd DMF (2 mL) and Pd/C was (10−15 wt%) added. The solution was degassed at −78 °C for 5 min and the flask was filled with H2. After 16 h at r.t., the reaction was complete. The solution was filtered over a pad of Celite® and concentrated under high vacuum. Purification over RP 18 silica gel eluting with H2O containing a few drops of 12 M HCl afforded 5-Tfm-Pro as its hydrochloride salt (0.061 g, 0.27 mmol, 100%). 1H NMR (300 MHz, D2O): δ = 4.41 (m, 2 H), 2.05−2.42 (m, 4 H). 13C NMR (75.45 MHz, D2O): δ = 171.2 (C), 123.0 (q, J CF = 278 Hz, C), 61.5 (CH), 59.5 (q, J CCF = 33.7 Hz, C), 27.1, 23.7 (CH2). 19F NMR (282.4 MHz, D2O): δ = −72.3 (d, J HF = 7.06 Hz, cis isomer), −73.0 (d, J HF = 7.34 Hz, trans isomer). MS (ESI−): m/z = 181.94 ([M − H]). HRMS (ESI−): m/z [M − H] calcd for C6H7NO2F3: 182.0429; found: 182.0430.
  • 31 Abdel-Magid AF, Carson KG, Harris BD, Maryanoff CA, Shah RD. J. Org. Chem. 1996; 61: 3849